Track the 인터로조 stock price and the full management transaction log of the company, a listed equity based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 인터로조 has published 53 public disclosures. The latest transaction was disclosed on 20 July 2026 (Purchase). Among the most active insiders: 노시철. Every trade is free.
52
Insider Decl.
n/a
Thresholds
n/a
46 ops.
Buy Volume
n/a
3 ops.
Sell Volume
16Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
인터로조 is a company operating in the health and pharmaceutical sector, listed on the XKRX. It specializes in the development and distribution of pharmaceutical products.